Home » Unit Operations » Unit Operations » David Brennan Speaks On Cancer Cures Through Innovation
David Brennan Speaks On Cancer Cures Through Innovation
PharmaManufacturing.com
10/06/2009
CEO, David Brennan, delivered a speech titled “Improving the prognosis: cancer cures through innovation” at the 2009 Medical Innovation Summit, a major industry conference run by the internationally renowned Cleveland Clinic.
Brennan explained some of AstraZeneca’s recent experiences and examined what they tell us about the way forward for medical innovation, particularly in oncology.
The three themes Brennan picked out were personalisation, partnership and policy – main drivers which can bring about progress in medical science and better health outcomes for the patient.
To read more, click here.
More News:
- 03/18/2010 Teva Beats Out Pfizer & Activa in 3.5BN Rationpharm Generics DealFrom CTV.ca
- 03/18/2010 Johnson & Johnson CEO Weldon Gets 11% 2009 Raise, to $25.6MFrom AP.com
- 03/17/2010 $75 Million Drug Heist is Bitter Pill for LillyFrom IndyStar.com
- 03/17/2010 R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges
- 03/15/2010 Diabetes Drug From Lilly, Amylin Under ScrutinyFrom Forbes.com
- 03/12/2010 AstraZeneca Inks First Generic Drugs DealFrom Business.timesonline.co.uk
- 03/12/2010 AstraZeneca Job Cuts Reflect New Landscape For Drug InnovationFrom FT.com
- 03/10/2010 Novartis Goes Wireless for Process and Plant Info
- 03/10/2010 Concerns Raised about Tromethamine ContaminationFrom Rx-360
- 03/09/2010 Pittcon 2010: Thermo Fisher Scientific Continues in Growth Mode
- All news »
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page